Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Tsutomu Hachiya"'
Autor:
Yasuyuki Ikezawa, Ryo Morita, Hidenori Mizugaki, Kazunari Tateishi, Keiki Yokoo, Toshiyuki Sumi, Hajime Kikuchi, Yasuo Kitamura, Atsushi Nakamura, Maki Kobayashi, Mari Aso, Nozomu Kimura, Fumiaki Yoshiike, Furuta Megumi, Hisashi Tanaka, Motoki Sekikawa, Tsutomu Hachiya, Keiichi Nakamura, Fumihiro Hommura, Noriaki Sukoh, Kenichiro Ito, Takashi Kikuchi, Toshihiko Agatsuma, Hiroshi Yokouchi
Publikováno v:
Cancer Medicine, Vol 13, Iss 14, Pp n/a-n/a (2024)
Abstract Background Selecting pembrolizumab monotherapy (MONO) or pembrolizumab plus platinum‐based chemotherapy (COMB) for patients with nonsmall cell lung cancer (NSCLC) and high programmed death‐ligand 1 (PD‐L1) expression is an important is
Externí odkaz:
https://doaj.org/article/9abe2da6e7c64c909348f0fdd32c3056
Autor:
Tatsuya Yazaki, Masanobu Kimoto, Ayumi Minagawa, Takashi Maruno, Miwa Yamanaka, Kei Sonehara, Mineyuki Hama, Toshitsugu Nakamura, Shintaro Kanda, Masayuki Hanaoka, Tsutomu Hachiya
Publikováno v:
American Journal of Case Reports; 6/1/2024, Vol. 25, p1-7, 7p
Autor:
Yasuyuki Ikezawa, Hidenori Mizugaki, Ryo Morita, Kazunari Tateishi, Keiki Yokoo, Toshiyuki Sumi, Hajime Kikuchi, Yasuo Kitamura, Atsushi Nakamura, Maki Kobayashi, Mari Aso, Nozomu Kimura, Fumiaki Yoshiike, Megumi Furuta, Hisashi Tanaka, Motoki Sekikawa, Tsutomu Hachiya, Keiichi Nakamura, Mototsugu Shimokawa, Satoshi Oizumi
Publikováno v:
Cancer Science. 113:2109-2117
It is not clear whether pembrolizumab monotherapy (MONO) or pembrolizumab plus platinum-based chemotherapy (COMB) should be selected for patients with advanced non-small-cell lung cancer (NSCLC) exhibiting high PD-L1 expression (tumor proportion scor
Autor:
Mineyuki Hama, Masanobu Kimoto, Tsutomu Hachiya, Shunnosuke Tanaka, Kotaro Gomi, Taro Hirabayashi
Publikováno v:
Internal Medicine
We herein report a rare case of advanced lung adenocarcinoma with central diabetes insipidus due to pituitary metastasis. Although treatment with gefitinib was dramatically effective, the symptoms of diabetes insipidus did not improve. Radiotherapy f
Autor:
Gen Ideura, Norihiko Goto, Akemi Matsuo, Masayuki Hanaoka, Masanori Yasuo, Atsuhito Ushiki, Hiroshi Yamamoto, Tsutomu Hachiya, Makoto Kosaka, Jumpei Akahane, Yoshiaki Kitaguchi, Yoshitaka Yamazaki, Yosuke Wada, Yuichi Ikuyama
Publikováno v:
Journal of Infection and Chemotherapy
Introduction Risk factors for seriously ill coronavirus disease 19 (COVID-19) patients have been reported in several studies. However, to date, few studies have reported simple risk assessment tools for distinguishing patients becoming severely ill a
Autor:
Yasuo Kitamura, Hidenori Mizugaki, Yasuyuki Ikezawa, Ryo Morita, Kazunari Tateishi, Keiki Yokoo, Toshiyuki Sumi, Hajime Kikuchi, Atsushi Nakamura, Maki Kobayashi, Mari Aso, Nozomu Kimura, Fumiaki Yoshiike, Megumi Furuta, Hisashi Tanaka, Motoki Sekikawa, Tsutomu Hachiya, Keiichi Nakamura, Satoshi Oizumi
Publikováno v:
Annals of Oncology. 33:S524
Autor:
Masayuki Hanaoka, Kazunari Tateishi, Tomonobu Koizumi, Akio Morikawa, Akemi Matsuo, Keiichirou Takasuna, Nobutoshi Morozumi, Toshihiko Agatsuma, Takashi Kobayashi, Hozumi Tanaka, Tsutomu Hachiya, Kei Sonehara, Fumiaki Yoshiike, Yasushi Ono, Takeshi Masubuchi
Publikováno v:
Thoracic Cancer
BACKGROUND In the LUX-Lung 3 and LUX-Lung 6 trials, afatinib improved overall survival in previously untreated patients with EGFR 19del mutated non-small cell lung cancer (NSCLC) compared to chemotherapy. The appropriate management of adverse events
Autor:
Shigeru Koyama, Tsutomu Hachiya, Masayuki Hanaoka, Akemi Matsuo, Yuichi Ikuyama, Atsuhito Ushiki, Makoto Kosaka, Fumiaki Yoshiike, Jumpei Akahane
Publikováno v:
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 27(5)
Introduction There is an increasing incidence of Pneumocystis pneumonia (PcP) among individuals without human immunodeficiency virus (HIV) infection (non-HIV PcP). However, prognostic factors for patients with non-HIV PcP have not been identified. Mo
Autor:
Jumpei Akahane, Masayuki Hanaoka, Fumiaki Yoshiike, Tsutomu Hachiya, Shigeru Koyama, Atsuhito Ushiki, Akemi Matsuo, Makoto Kosaka, Yuichi Ikuyama
Background: There is an increasing incidence of Pneumocystis pneumonia among individuals without the human immunodeficiency virus (HIV) infection (non-HIV Pneumocystis pneumonia). However, the prognostic factors for patients with non-HIV Pneumocystis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83d24732da47a81f2dea18c5be9de49e
https://doi.org/10.21203/rs.3.rs-52173/v1
https://doi.org/10.21203/rs.3.rs-52173/v1
Autor:
Tomonobu Koizumi, Kazunari Tateishi, Tsutomu Hachiya, Takashi Kobayashi, Kei Sonehara, Fumiaki Yoshiike, Yuuki Wakatsuki, Manabu Yamamoto, Takeshi Masubuchi, Kazuya Hirai, Toshirou Fukushima
Publikováno v:
Cancer Chemotherapy and Pharmacology. 81:1043-1050
This phase II study was performed to evaluate the efficacy and safety of cisplatin/pemetrexed combined with 15 mg/kg of bevacizumab followed by pemetrexed/bevacizumab maintenance therapy as first-line chemotherapy in advanced non-squamous non-small c